Cite
HARVARD Citation
Yao, J. et al. (2022). Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial. Current medical research and opinion. pp. 1797-1806. [Online].